Saturday, July 11, 2026

pharma · B-Cell Non-Hodgkin Lymphoma

Qian Wenbin

News and analysis for Qian Wenbin on NovaPharmaNews — regulatory, clinical, and market coverage.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
4
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Qian Wenbin — regulatory, clinical, and market coverage.

News and analysis for Qian Wenbin on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Qian Wenbin yet.

Back to company overview →